Copyright
©The Author(s) 2003.
World J Gastroenterol. Jul 15, 2003; 9(7): 1618-1620
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1618
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1618
Variables | Number of cases | P | |
Fatty Liver (-) | Fatty Liver (+) | ||
Contraceptives | |||
No | 117 | 94 | |
Yes | 2 | 4 | 0.28 |
Tamoxifen | |||
No | 25 | 13 | |
Yes | 94 | 85 | 0.14 |
Chemotherapy | |||
No | 52 | 49 | |
Yes | 58 | 47 | 0.59 |
Hepatitis C | |||
No | 116 | 88 | |
Yes | 10 | 3 | 0.031 |
Diabetes | |||
No | 113 | 92 | |
Yes | 6 | 6 | 0.73 |
Overweight | |||
No | 71 | 21 | |
Yes | 48 | 77 | < 0.0001 |
Hyperlipidemia | |||
No | 106 | 71 | |
Yes | 13 | 27 | 0.017 |
- Citation: Chu CH, Lin SC, Shih SC, Kao CR, Chou SY. Fatty metamorphosis of the liver in patients with breast cancer: Possible associated factors. World J Gastroenterol 2003; 9(7): 1618-1620
- URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1618